Conclusion
The PKD1 inhibits oxidative stress and apoptosis and promotes angiogenesis, hence increasing random flaps survival rate. Further research is required to determine whether PKD1 has a beneficial effect on clinical flap surgery patients. Also, the underlying mechanism differences between endogenous and exogenous PKD1 should be validated.